US health insurers mixed after CMS releases 2027 ratings
BUZZ-US health insurers mixed after CMS releases 2027 ratings ** Shares of US health insurers mixed in extended trading following US Centers for Medicare & Medicaid Services' Medicare Advantage plan ratings for 2027
** CMS says 71% of Medicare Advantage prescription drug enrollees in 4-star or higher plans for 2027
** Humana HUM.N shares rise about 14% in extended trading, while UnitedHealth UNH.N and CVS Health CVS.N shares down about 0.5% and 4%, respectively.
** The agency issues star ratings for Medicare Advantage and prescription drug plans on a scale of one to five, with five stars indicating the highest quality
** CMS also said that about 37% of Medicare Advantage prescription drug contracts that will be offered in 2027 earned four stars or higher for their overall rating
(Reporting by Pragyan Kalita in Bengaluru)
Recent news on CVS Health
See all newsHealth Rounds: GLP-1 drugs tied to heart improvements in patients with obesity and heart failure
US health insurers fall for third day on CMS audit proposal, Medicare-for-All concerns
Health insurers extend decline on proposed new rule to curb fraud
Health insurers extend decline on proposed new rule to curb fraud
UnitedHealthcare to expand program paying pharmacists for medical services